Chronic heart failure (CHF) is a progressive syndrome involving activation of neuro-humoral mechanisms and inflammation resulting in a degenerative process with muscle wasting and deconditioning. 1 The skeletal muscle hypothesis proposed by Coats and Piepoli described this phenomenon of deconditioning, recognized as one of the main factors per se aggravating the underlying pathophysiology in CHF 2 paving the way for exercise training as an attractive additional treatment option.
Single centre studies showed that exercise training improved peripheral adaptions, reduced inflammation, reduced muscle wasting and reduced neuro-humoral activation. This was associated with improved exercise capacity and reduced symptoms. 3 Subsequently, the effect, also on hard endpoints, was confirmed in the ExTraMATCH meta-analysis published in 2004 by Piepoli and co-workers, who showed a statistically significant effect on mortality. 4 
Current paper
In the current issue of the journal Ioannis D Lauotoris is reviewing the literature forming the evidence for the 1 A recommendation for exercise training in CHF. 5 After very encouraging results from single centre studies and meta-analysis he correctly addresses the disappointing results from the large, modern, randomized controlled trials (RCTs) on aerobic exercise training (AET) in this population. The Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) demonstrated that AET was safe, but the reductions in the primary endpoint of all-cause mortality or hospitalization and in key secondary clinical endpoints was not statistically significant. After adjustment for highly prognostic predictors of the primary endpoint, exercise training was associated with modest significant reductions for both all-cause mortality or hospitalization and cardiovascular mortality or heart failure hospitalization. 6 The author then turns to the other modes of exercise training, such as high intensity aerobic interval training (HIIT). A pilot study indicated that HIIT, but not AET, might increase central haemodynamics also in patients with CHF, 7 but this was not confirmed in the following randomized controlled clinical trial: Study of Myocardial Recovery After Exercise Training in Heart Failure (SMARTEX).
8 Disappointingly, the effect on peak VO 2 in the SMARTEX trial was quite similar in aerobic endurance training and in HIIT.
In accordance with these recent studies, a large metaanalysis evaluating seven meta-analyses and the publications of 48 RCTs suggests that exercise prevents all-cause hospitalizations and improves quality of life but has no effect on mortality. 9 The author concludes that the 'cre`me de la cre`me' exercise programme for the CHF population remains to be found. This view is further supported by the introduction of The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool. 10 The lack of a 'cre`me de la cre`me' exercise programme is also illustrated in a recent review of current guidelines which identified differences in recommendations between key cardiology and cardiac rehabilitation organizations, further complicating the picture. 11 The American Heart Association, the American Association of Cardiovascular and Pulmonary Rehabilitation, the Canadian Association of Cardiac Rehabilitation and the European Association of Preventive Cardiology endorse a progression from moderate-to vigorousintensity aerobic exercise in conjunction with resistance training, whereas the Australasian, British, French and Japanese organizations recommend lower-intensity aerobic exercise and/or less technical exercise testing, with a reduced focus on resistance training. In addition there are differences in the recommendations for using electrocardiographic monitoring both before starting an exercise training programme and during exercise training sessions.
The considerable heterogeneity across RCTs in the magnitude of improvement in exercise capacity is also complicating the issue. A large analysis of 61 controlled studies showed that whilst higher exercise intensities were associated with a greater level of post-rehabilitation exercise capacity, there was no strong evidence to support other intervention, patient or trial factors to be predictive. 12 Inconsistency between the early single centre studies and the RCTs So, why were the encouraging results from previous mechanistic studies, single centre studies and metaanalyses not confirmed in the RCTs? An obvious explanation is the difference in medical therapy in the 1980s and early 1990s compared with current modern optimal medical therapy (OMT). The early studies were without beta-blockers and aldosterone antagonists. In addition device therapy was hardly implemented in clinical practice. Difference in results from 'historic' studies 13 and recent studies comprising OMT indicate that the effects of exercise training on autonomic balance are less pronounced in patients on modern OMT including aldosterone antagonists and beta-blockers. 14, 15 Some studies also indicate that the pathological muscle fibre shift is less pronounced in patients on OMT. 16 In addition, the raised levels of tumour necrosis factor (TNF) in CHF and the reduced levels of TNF after aerobic training has been difficult to confirm in patients on modern OMT. [17] [18] [19] Nonetheless, improved physical capacity is also associated with improved quality of life 20 and reduced levels of anxiety and depression. 21 Consequently, the high percentage on OMT, with 95% being on beta-blockers and angiotensin-converting enzyme (ACE) antagonists or angiotensin receptor antagonists, in addition to high use of implantable defibrillators or heart failure pacemakers makes the HF-ACTION a contemporary cohort reflecting high standard of care. 22 Also in the SMARTEX study all patients were considered to be on optimal medical treatment. This is in contrast to the ExTraMATCH meta-analysis, in which 73% of the patients were on ACE inhibitors, but only 12% were on beta-blockers and none were on aldosterone antagonists. 4 OMT has effects on both central and peripheral heart failure pathology. The patients are more mobilized, which in turn has an additional beneficial effect. Thus, OMT is perhaps modulating the effects of AET. On the other hand OMT makes it possible to be active and to perform exercise training. In addition the large beneficial effects of modern OMT and device therapy may further 'dilute' the positive effects of exercise training.
Another explanation for the differences between previous studies and the large RCTs may be related to functional capacity. The mean New York Heart Association (NYHA) class in the ExTraMATCH meta-analysis was 2.5-2.6. This differs from the populations in SMARTEX, where 56-75% of the patients were in NYHA class 2 whereas the numbers in HF-ACTION were 60-65%, which means that the patients have slight limitation of physical activity. This is associated with objective class B that is defined by objective evidence of minimal cardiovascular disease. 23 An additional improvement in functional capacity might thus be very difficult to achieve.
Moreover, the modest effect in HF-ACTION was partly explained by dose (too low intensity) and adherence to therapy. Lack of adherence has several explanations related to age, anxiety, depression, lack of resources for transportation, lack of capacity, lack of symptoms, However, you have got to take the pill with the prescribed dose and interval to have an effect.
In addition the population in the HF-ACTION were more heterogeneous than in the early pilot studies with 40% from minority populations and 28% women.
Thus, several mechanisms are operative when the positive effects of the historic small, single centre studies were not fully confirmed in the large RCTs and meta-analyses.
However, waiting for the evaluation of the EXPERT tool in clinical practice, the author turns his focus towards the extension of the muscle hypothesis in CHF as described by Piepoli and Coates, adding reduction of muscle bulk, skeletal muscle fibre atrophy and respiratory muscle pathology with metabolic and structural derangements to the original hypothesis.
Strength training per se is reported to improve peak VO 2 . Moreover, there are indications of benefit in lipid and blood pressure control and insulin sensitivity, especially in combination with aerobic exercise. 24 The author launches the combined exercise training approach based on the additional effects demonstrated for strength training when added to AET in heart failure. 25, 26 This is in accordance with a recently published meta-analysis including studies evaluating the combination of strength training and AET in which the investigators found that the combined approach gave a statistically significant increased improvement in physical capacity, including peak VO 2 , 27 compared with AET. However, although strength training is associated with several general positive effects, including improved bone formation, enhanced muscle mass, strength and functional ability, most studies are old, published 10-15 years ago, and include few patients.
In addition to aerobic exercise training and strength training a third mode, (inspiratory) respiratory training, is included in his model. Mancini showed early that selective respiratory exercise training improves exercise capacity in patients with heart failure. 29 Later, experimental studies have shown that this mode of exercise training is associated with an increase in diaphragm citrate synthase activity and improved haemodynamic function. 30 In addition, respiratory muscle training also improves heart rate variability, chemo-reflex response and respiratory mechanics. 31 A meta-analysis including 11 studies on inspiratory muscle training (IMT) before 2012 containing data on 287 participants showed that IMT improves cardiorespiratory fitness and quality of life to a similar magnitude as conventional AET. IMT may therefore provide an initial alternative to the more severely de-conditioned CHF patients, who may then transition to conventional exercise training. 32 Mancini and colleagues, in Circulation in 1995, first published the concept of respiratory exercise training. However, the study was very small, with significant baseline differences between treatment and control group. Twenty-four patients were included and eight patients completed the training programme. The left ventricular ejection fraction (LVEF) of the intervention group was 20% versus 24% in the control group. The intervention group had a mean NYHA class of 2.8 whereas it was 2.3 in the control group. In addition peak VO 2 was 11 ml/kg per min in the intervention group and 16 ml/kg per min in the control group. Dyspnoea during activities of daily living was subjectively improved in the majority of trained patients. This was an important contribution to the bulk of knowledge of pathophysiology in CHF, but the conclusion was based on only eight patients in the intervention group, with relatively different baseline characteristics in the intervention group and the control group.
On the other hand, the randomized multicentre Vent-HeFT trial demonstrated that IMT combined with aerobic training provided additional benefits in functional and serum biomarkers in patients with moderate CHF. In this study the patients were on OMT, but there was still some weaknesses; that is, a large difference in baseline characteristics between centres (peak VO 2 ). However, these findings may advocate for application of IMT in cardiac rehabilitation programmes. 33 The multisite training approach As in modern pharmacotherapy for heart failure and modern cardiac resynchronization therapy, the training intervention might have to be aimed against multiple targets; that is, different muscle systems with different modes of training. The combination of aerobic training with strength or resistance training is a growing approach with an increasing bulk of evidence documenting the effects of combining these two modes to obtain peripheral 'normalization' of structure and to improve muscle bulk and muscle strength. This is in accordance with a recent meta-analysis, in which combined exercise/IMT has been shown to improve maximal inspiratory pressure and quality of life in patients with CHF and it is therefore considered for inclusion in cardiac rehabilitation programmes. 34 The author has elegantly reviewed all three entities of muscle pathology and emphasized that low aerobic capacity, reduced peripheral muscle strength and pathological respiratory muscle function are all associated with exercise severity, exercise intolerance and prognosis in the CHF population and extends the training intervention to a triple intervention approach by adding IMT. Due to the weaknesses of the early studies and the modest response to exercise training in the modern RCTs as outlined above, his suggestion of a triple approach seems to be attractive. This is further supported by a recently published study on 46 heart failure patients that showed that non-invasive ventilatory support combined with combined aerobic and resistance training provides additional benefits for dyspnoea and quality of life. 35 However, one should keep in mind also the weakness of the previous studies on strength training and respiratory training.
The author should be congratulated for taking the combined approach further and for planning to test the current hypothesis in a prospective, large, multi-centre exercise training trial comparing all possible combinations of exercise intervention in CHF patients in NYHA class II-III with LVEF <35% on OMT and modern device therapy -the Aerobic Resistance, InSpiratory Training OutcomeS in Heart Failure trial (Aristos-HF trial) -to document the evidence for what the author calls the 'cre`me de la cre`me' exercise training programme for CHF patients.
The target population has to be powered to provide evidence for beneficial effects in both pathophysiological measures and functional capacity as well as in such clinical endpoints as rehospitalization for heart failure. In addition, adherence and training intensities must be monitored to assure optimal dose and compliance. Then we might have an answer to whether organized exercise training still is an attractive approach in the population of CHF patients on modern OMT with modest symptoms.
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